Levetiracetam Noridem

Levetiracetam, the active ingredient in Levetiracetam Noridem, is an anticonvulsant presented as an intravenous solution for intravenous use. It is used as adjunctive therapy for partial‑onset, myoclonic and primary generalized tonic‑clonic seizures in patients requiring parenteral treatment.

GNH USA supplies Levetiracetam Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic agent used to control seizure activity across several epilepsy syndromes. - Partial‑onset seizures: reduces seizure frequency when added to existing therapy. - Myoclonic seizures: provides adjunctive seizure control in patients with myoclonic epilepsy. - Primary generalized tonic‑clonic seizures: helps achieve better seizure control as add‑on therapy.

Levetiracetam may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: generalized tiredness or reduced energy. - Nausea: feeling of stomach upset, sometimes with vomiting. - Irritability: mood changes or increased agitation. - Headache: mild to moderate cranial pain. - Somnolence: excessive sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

When using Levetiracetam Noridem, several precautions should be observed to ensure safe administration and optimal therapeutic outcome. - Renal impairment: adjust dose or monitor plasma levels in patients with reduced kidney function. - Pregnancy: category B1; use only if benefit outweighs potential risk. - Concomitant CNS depressants: monitor for additive sedation or respiratory depression. - Psychiatric history: observe for emergence of mood changes or suicidal thoughts. - Allergies: avoid if known hypersensitivity to levetiracetam or formulation components. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenobarbital: can lower levetiracetam levels, potentially decreasing seizure control.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines, opioids): may increase CNS depression. - Antidepressants (e.g., SSRIs): monitor for mood alterations. - Immunosuppressants (e.g., cyclosporine): observe for possible pharmacokinetic changes.